Escitalopram Pill

Phase 1Small molecule

NNYU Langone Health

Escitalopram Pill is one of 75 small molecule programs targeting Cognitive impairment. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cognitive ImpairmentActive, not recruiting

Anxiety DisorderActive, not recruiting

Cognitive ImpairmentPhase 1

Active, not recruiting

Anxiety DisorderPhase 1/Phase 2

Active, not recruiting

Competition

Competitive Landscape

279 competitors in Cognitive Impairment

#DrugCompanyPhaseTrials

Actos

Takeda

Phase 3

3 2

Farxiga

AstraZeneca

Phase 3

1 3

Provigil

NNuvo Research GmbH

Phase 3

1 4

Xarelto

WWim Janssens

Phase 3

1 5

Aquasol E

NNational Eye Institute (NEI)

Phase 3

1 6

Viagra

VViatris Specialty LLC

Phase 3

1 7

Donepezil Hydrochloride

Eisai

Phase 3

3 8

Statins

Sanofi

Phase 3

1 9

Galantamine Hydrobromide

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 3

4 10

Karx-EC

Bristol-Myers Squibb

Phase 3

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Cognitive impairment1 trial

A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol

Terminated·NNYU Langone Health·Phase 1·NCT03274817·5 enrolled

Treatment1 trial

Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders

Unknown status·PPeking University··NCT03294525·400 enrolled

Anxiety Disorder1 trial

Chinese Herb for the Treatment of Depression and Anxiety Disorders

Unknown status·MMazra Mental Health Center·Phase 1/2·NCT03323697·60 enrolled

Depression1 trial

Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)

Completed·HHoward Aizenstein·Phase 4·NCT03128021·57 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Escitalopram Pill. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Escitalopram Pill compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Escitalopram Pill. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — NYU Langone Health company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: NNYU Langone Health

Escitalopram Pill

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Cognitive impairment1 trial

Treatment1 trial

Anxiety Disorder1 trial

Depression1 trial

References

Drug Info

Quick Facts

Related News